Johns Hopkins Announces New Clinical Trial For Post-Treatment Lyme Disease Using Psilocybin
Johns Hopkins Center for Psychedelic and Consciousness Research (CPCR) is embarking on a new clinical trial for individuals with Post-Treatment…
Gisèle Wertheim Aymes1 August 2022